As of December 2024 Genscript Biotech has a market cap of NZ$4.77 Billion. This makes Genscript Biotech the world's 3756th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.